Xeptiva Therapeutics

About:

Xeptiva is a biotechnology company developing therapies for the treatment of chronic inflammation in companion animals

Website: https://www.xeptiva.com/

Twitter/X: xeptiva

Top Investors: NDLATAM, Uruguay Biotech Ventures, Fen Ventures, iThink VC, Zentynel Frontier Investments

Description:

Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.

Total Funding Amount:

$3.15M

Headquarters Location:

Montevideo, NA - Uruguay, Uruguay

Founded Date:

2021-01-01

Contact Email:

info(AT)xeptiva.com

Founders:

Emiliano Trias, Josefina Correa, Luis Barbeito

Number of Employees:

1-10

Last Funding Date:

2024-09-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai